POINT/COUNTERPOINT: Systemic α-particles are likely to yield more important advances in radiotherapy than are protons
Med Phys
.
2015 Jul;42(7):3785-7.
doi: 10.1118/1.4919281.
Authors
Barry J Allen
1
,
Alexei V Chvetsov
2
,
Colin G Orton
Affiliations
1
Faculty of Medicine, University of Western Sydney, Liverpool, NSW 2150, Australia (Tel: 61 (0)2 9524 2502; E-mail: bja1940@optusnet.com.au).
2
Department of Radiation Oncology, University of Washington Medical Center, Seattle, Washington 98195 (Tel: 206-598-5971; E-mail: chvetsov@uw.edu).
PMID:
26133580
DOI:
10.1118/1.4919281
No abstract available
Publication types
Comparative Study
MeSH terms
Humans
Neoplasms / radiotherapy
Neutrons / therapeutic use
Proton Therapy / methods*
Radioimmunotherapy / methods*
Radiotherapy Dosage
Substances
Protons